738
Views
1
CrossRef citations to date
0
Altmetric
Research Article

CpG promoter methylation status is not a prognostic indicator of gene expression in beryllium challenge

, &
Pages 417-427 | Received 23 Jul 2015, Accepted 27 Oct 2015, Published online: 16 Dec 2015

References

  • Alam MP, Datta S, Majumdar S, Mehta AK, Baskaran S, Gulati N, Brahmachari V. 2010. Comparative analysis of DNA methylation in transgenic mice with unstable CGG repeats from FMR1 gene. Epigenetics 5:241–248.
  • Antequera F. 2003. Structure, function and evolution of CpG island promoters. Cell Mol Life Sci 60:1647–1658.
  • Baccarelli A, Bollati V. 2009. Epigenetics and environmental chemicals. Curr Opin Pediatr 21:243–251.
  • Baggerly KA, Morris JS, Coombes KR. 2004. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 20:777–785.
  • Bird AP. 1986. CpG-rich islands and the function of DNA methylation. Nature 321:209–213.
  • Bollati V, Marinelli B, Apostoli P, Bonzini M, Nordio F, Hoxha M, Pegoraro V, Motta V, Tarantini L, Cantone L, et al. 2010. Exposure to metal-rich particulate matter modifies the expression of candidate microRNAs in peripheral blood leukocytes. Environ Health Perspect 118:763–768.
  • Bost TW, Riches DW, Schumacher B, Carre PC, Khan TZ, Martinez JA, Newman LS. 1994. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for TNFα and IL-6 but not IL-1β. Am J Respir Cell Mol Biol 10:506–513.
  • Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, Das S, Ghosh N, Chatterjee D. 2006. DNA hyper-methylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci 89:431–437.
  • Chen H, Ke Q, Kluz T, Yan Y, Costa M. 2006. Nickel ions increase histone H3 lysine-9 di-methylation and induce transgene silencing. Mol Cell Biol 26:3728–3737.
  • Hamada H, Sawyer RT, Kittle LA, Newman LS. 2000. Beryllium-stimulation does not activate transcription factors in a mouse hybrid macrophage cell line. Toxicology 143:249–261.
  • Hanna CW, Bloom MS, Robinson WP, Kim D, Parsons PJ, vom Saal FS, Taylor JA, Steuerwald AJ, Fujimoto VY. 2012. DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF. Human Reprod 27:1401–1410.
  • He J, Qian X, Carpenter R, Xu Q, Wang L, Qi Y, Wang ZX, Liu LZ, Jiang BH. 2013. Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway. Toxicol Sci 134:26–38.
  • Huang YC, Hung WC, Chen WT, Yu HS, Chai CY. 2011. Effects of DNMT and MEK inhibitors on the expression of RECK, MMP-9, -2, uPA and VEGF in response to arsenite stimulation in human uroepithelial cells. Toxicol Lett 201:62–71.
  • Infante PF, Newman LS. 2004. Beryllium exposure and chronic beryllium disease. Lancet 363:415–416.
  • Jiang G, Xu L, Song S, Zhu C, Wu Q, Zhang L, Wu L. 2008. Effects of long-term low-dose cadmium exposure on genomic DNA methylation in human embryo lung fibroblast cells. Toxicology 244:49–55.
  • Kelleher PC, Martyny JW, Mroz MM, Maier LA, Ruttenber AJ, Young DA, Newman LS. 2001. Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med 43:238–249.
  • Lee YW, Klein CB, Kargacin B, Salnikow K, Kitahara J, Dowjat K, Zhitkovich A, Christie NT, Costa M. 1995. Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: A new model for epigenetic carcinogens. Mol Cell Biol 15:2547–2557.
  • Li Q, Ke Q, Costa M. 2009. Alterations of histone modifications by cobalt compounds. Carcinogenesis 30:1243–1251.
  • Lou J, Wang Y, Yao C, Jin L, Wang X, Xiao Y, Wu N, Song P, Song Y, Tan Y, et al. 2013. Role of DNA methylation in cell cycle arrest induced by Cr (VI) in two cell lines. PLoS One 8:e71031.
  • Maeda T, Guan JZ, Higuchi Y, Oyama J, Makino N. 2009. Aging-related alterations of sub-telomeric methylation in sarcoidosis patients. J Gerontol 64:752–760.
  • Maier LA, Martyny JW, Liang J, Rossman MD. 2008. Recent chronic beryllium disease in residents surrounding a beryllium facility. Am J Respir Crit Care Med 177:1012–1017.
  • Meehan R, Lewis J, Cross S, Nan X, Jeppesen P, Bird A. 1992. Transcriptional represssion by methylation of CpG. J Cell Sci Suppl 16:9–14.
  • Newman LS, Kreiss K. 1992. Non-occupational chronic beryllium disease masquerading as sarcoidosis: Identification by blood lymphocyte proliferative response to beryllium. Am Rev Respir Dis 145:1212–1214.
  • Newman LS, Kreiss K, King TE, Seay S, Campbell PA. 1989. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis 139:1479–1486.
  • Newman LS, Mroz MM, Balkissoon R, Maier LA. 2005. Beryllium sensitization progresses to chronic beryllium disease: A longitudinal study of disease risk. Am J Respir. Crit. Care Med 171:54–60.
  • Niedzwiecki MM, Hall MN, Liu X, Oka J, Harper KN, Slavkovich V, Ilievski V, Levy D, van Geen A, Mey JL, et al. 2013. A dose-response study of arsenic exposure and global methylation of peripheral blood mononuclear cell DNA in Bangladeshi adults. Environ Health Perspect 121:1306–1312.
  • Rozhon W, Baubec T, Mayerhofer J, Mittelsten Scheid O, Jonak C. 2008. Rapid quantification of global DNA methylation by isocratic cation exchange high-performance liquid chromatography. Anal Biochem 375:354–360.
  • Sanders AP, Smeester L, Rojas D, DeBussycher T, Wu MC, Wright FA, Zhou YH, Laine JE, Rager JE, Swamy GK, et al. 2014. Cadmium exposure and the epigenome: Exposure-associated patterns of DNA methylation in leukocytes from mother-baby pairs. Epigenetics 9:212–221.
  • Sawyer RT, Fadok VA, Kittle LA, Maier LA, Newman LS. 2000a. Beryllium-stimulated apoptosis in macrophage cell lines. Toxicology 149:129–142.
  • Sawyer RT, Kittle LA, Hamada H, Newman LS, Campbell PA. 2000b. Beryllium-stimulated production of TNFα by a mouse hybrid macrophage cell line. Toxicology 143:235–247.
  • Silveira LJ, Yang IV, Li L, Mac Phail K, Hamzeh NY, Fingerlin T, Maier LA. 2013. Epigenetic alterations and the development of chronic beryllium disease. Philadelphia, PA: American Thoracic Society.
  • Tinkle SS, Kittle LA, Newman LS. 1999. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease. J Immunol 163:2747–2753.
  • Tinkle SS, Kittle LA, Schumacher BA, Newman LS. 1997. Beryllium induces IL-2 and IFNγ in berylliosis. J Immunol 158:518–526.
  • Verstraeten SV, Aimo L, Oteiza PI. 2008. Aluminium and lead: Molecular mechanisms of brain toxicity. Arch Toxicol 82:789–802

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.